Product
Ferric Carboxymaltose + Tranexamic Acid
1 clinical trial
1 indication
Indication
Gynecological CarcinomaClinical trial
Perioperative Management With Ferric Carboxymaltose and Tranexamic Acid to Reduce Transfusion Rate in Gynaecological Carcinoma Surgery: a Single-blind, Mono-centre, Randomized TrialStatus: Recruiting, Estimated PCD: 2026-12-31